The 2022 COA/CORS/CORA Annual Meeting
Tuesday, June 15
SIMPLICITY: The Next Chapter of Robotics and Digital
Please Join us at the Canadian Orthopaedic Association Annual Meeting to hear from world-renowned surgeons Drs. Brent Lanting, Mark Clatworthy and John Wright as they discuss the future of robotics and digital. They will discuss how and why robotics is beneficial in a public healthcare system and how the latest technologies is addressing some key needs, concerns & factors in knee arthroplasty.
The Future of Personalized Knee Care
As a proud sponsor of the Canadian Orthopaedic Association, we invite you to join our symposium, The Future of Personalized Knee Care.
Robotic-assisted surgery is modernizing orthopedic care. Our panelists will discuss the role of robotics in the Canadian healthcare system and their experience with the ROSA® Knee System to provide a practical understanding of incorporating new technology for primary knee arthroplasty into clinical practice. Following on this innovative technology, an introduction to the Persona® Revision Knee System will reference case-based examples to address current issues commonly seen in revision surgery and how the Persona Knee portfolio provides a continuum of care.
Wednesday, June 16
Canada Meet CORI: Real Intelligence in Modern Orthopaedic Practice
2:45 – 3:45PM EDT
We invite you to join an interactive panel discussion with Dr Jimmy Chow and Dr David Rovinsky as they share their experience using CORI Surgical System in their practice. Topics covered will include robotic assisted knee arthroplasty, emerging technology trends in Canada, and RI Insights the Smith+Nephew data analytics platform. Attendees may ask questions in the chat feature to be answered live by faculty guests.
Thursday, June 17
The MTF Advantage – A Case Series highlighting Allograft usage in Complex Knee Procedures
CONMED Canada in partnership with MTF Biologics would like to invite you to join us at the COA Annual Meeting for an engaging webinar with Dr. David Wasserstein and Dr. Danny Whelan. This interactive online presentation will begin with an overview of the MTF Advantage followed by case presentations on osteochondral allograft transplantation using the Missouri Osteochondral Allograft Preservation System (MOPS) and two stage revision ACLR utilizing allografts.
Have the Upper Hand Over Tendon and Ligament Injuries with a New Innovative Treatment
- Discuss the evidence supporting the role of SportVis™/STABHA™ in relieving pain and restoring tendon and ligament function;
- Describe the clinical role of, the only Health Canada-approved STABHA™, as an innovative treatment in tendon and ligament recovery.
- Incorporate the evidence for SportVis™ into use in current clinical practice
Saturday, June 19
A Randomized Trial–Decreased 90-Day Surgical Site Complication Rates with ciNPT after Revision Knee Arthroplasty
Surgical complications are reported in up to 10% of hip and knee arthroplasties. The incidence of postoperative surgical complications is influenced by co-morbidities, interoperative risk factors and duration and complexity of surgery. Join Dr. Carlos Higuera, Primary Investigator on a randomized control trial (RCT) that demonstrates significantly lower 90-day Surgical Site Complication (SSC) rates using ciNPT vs. standard of care.
Carlos Higuera, MD
Center Director Orthopaedics and Rheumatology
Chairman, Levitetz Department of Orthopedic Surgery Cleveland Clinic Adult Reconstruction Center
Carlos Higuera-Rueda is currently a staff surgeon at Cleveland Clinic Florida, where he divides his time between leadership, research and patient care. He is the Chairman of the Levitetz Department of Orthopaedic Surgery at Cleveland Clinic Florida and Director of the Orthopaedic and Rheumatology Center. Dr. Higuera completed his residency at Cleveland Clinic and a clinical fellowship at Thomas Jefferson University Hospital.
Dr. Higuera specializes in hip and knee arthroplasty surgery. He is interested in complex revision procedures including infections. His research interest is mainly in periprosthetic joint infections including diagnostic tools, patient optimization and overall outcomes after arthroplasty. He is currently working on developing new technologies to diagnose and treat such infections. He is the president of the Musculoskeletal Infection Society.
*Sponsor Spotlight Industry-led sessions are non-accredited. Attendees are not eligible to claim CME/MOC credits for participating in these specific sessions.